Rating Services
Rating Methodologies
Rating Results
Researches & Commentaries
News & Events
Login
EN
繁
简
ABOUT US
Company Profile
Vision and Mission
Directors and Management
RATING SERVICES
Overview of Rating Services
Rating Process
Credit Rating Principles
Rating Definition and Meaning
Ancillary Services and Other Services
Regulatory Disclosure
Further Regulatory Disclosure
Ratings Performance
Policies and Internal Control Mechanisms
Code Of Conduct
Internal Control Mechanisms
Record-keeping Policy
Rating Analyst Rotation Policy
Frequently Asked Questions
RATING METHODOLOGIES
Rating Methodologies
Request for Comment
RATING RESULTS
Issuer / Entity / Sovereign
Corporate Ratings
Bank Ratings
Non-bank Financial Institute Ratings
Sovereigns and Sub-Sovereigns
Others
Structure Finance
ABS
MBS
RESEARCHES & COMMENTARIES
All
Macroeconomics
Bond Markets
Credit Research
NEWS & EVENTS
All
Corporate News
Rating Announcement
Conference and Events
CREDIT INSIGHT
Login
EN
繁
简
Rating Services
Rating Methodologies
Rating Results
Researches & Commentaries
News & Events
HOME
ABOUT US
Company Profile
Vision and Mission
Directors and Management
RATING SERVICES
Overview of Rating Services
Rating Process
Credit Rating Principles
Rating Definition and Meaning
Ancillary Services and Other Services
Regulatory Disclosure
Further Regulatory Disclosure
Ratings Performance
Policies and Internal Control Mechanisms
Code Of Conduct
Internal Control Mechanisms
Record-keeping Policy
Rating Analyst Rotation Policy
Frequently Asked Questions
RATING METHODOLOGIES
Rating Methodologies
Request for Comment
RATING RESULTS
Issuer / Entity / Sovereign
Corporate Ratings
Bank Ratings
Non-bank Financial Institute Ratings
Sovereigns and Sub-Sovereigns
Others
Structure Finance
ABS
MBS
RESEARCHES & COMMENTARIES
All
Macroeconomics
Bond Markets
Credit Research
NEWS & EVENTS
All
Corporate News
Rating Announcement
Conference and Events
CREDIT INSIGHT
Rating Results
Home
Rating Results
Issuer / Entity / Sovereign
Taizhou Huaxin Pharmaceutical Investment Co., Ltd.
Overview
Back
Taizhou Huaxin Pharmaceutical Investment Co., Ltd.
Latest Creadit Rating
Long-Term Ratings
BBBg+
Outlook
Stable
Action Date
2024.6.13
Rating Report
Debt Rating
Senior Unsecured Debt Rating
--
Action Date
--
Overview
Press Release
Credit Rating
Overview
Press Release
Credit Rating
Press Release
Date
Title
Download
No matching results
Credit Rating
Please
login
first
Debt List
Please
login
first
Rating Record
Please
login
first
Issuer Category:
Corporates
Industry:
Local Infrastructure Investment and Financing
